Saturday, December 3, 2022
Home Tags Pharmaceuticals

Tag: pharmaceuticals

Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 56… –...

0
MONTREALĀ andĀ CHARLOTTE, N.C., May 27, 2022 /CNW/ -- Milestone Pharmaceuticals Inc. MIST, a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular...

NovaBay Pharmaceuticals Expands Top-Selling DERMAdoctor Kakadu C and Calm Cool +…...

0
Next generation of popular skincare solutions combine anti-aging and brightening agents to help reduce the appearance of wrinkles, fine lines, pores and discoloration...

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Aurinia Pharmaceuticals Inc. Inve… –...

0
NEW YORK, April 30, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of...

INVESTOR ALERT: Aurinia Pharmaceuticals Inc. Investors with Substantial Losses H… –...

0
SAN DIEGO, April 23, 2022 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of...

DEADLINE: Aurinia Pharmaceuticals Inc. Investors with Substantial Losses Have Op… –...

0
The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Aurinia Pharmaceuticals Inc. AUPH securities between May...

Rhizen Pharmaceuticals AG Presents Data on Its Differentiated PARP and DHODH...

0
Rhizen Pharma announces presentations at AACR showcasing its differentiated clinical stage PARP and DHODH programs Preclinical data on Rhizen's differentiated PARP inhibitor RP12146, indicates...

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Fennec Pharmaceuticals Inc. Investors… – Press...

0
NEW YORK, April 02, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of...

MONDAY DEADLINE: NRx Pharmaceuticals, Inc. Investors with Significant Losses Hav… –...

0
SAN DIEGO, March 17, 2022 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of NRx Pharmaceuticals, Inc. NRXP...

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages NRx Pharmaceuticals, Inc. Investo… – Press...

0
NEW YORK, March 13, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of...

Press Realease

Business News

Cricket

Weather News

Lifestyle

World News

UK / USA News

Local News